Australian Registry of Severe Drug Reactions
- Conditions
- drug allergyantibiotic allergyStevens-Johnson SyndromeToxic Epidermal NecrolysisDrug Reaction with Eosinophilia and Systemic SymptomsAcute Generalized Exanthematous PustulosisInflammatory and Immune System - AllergiesInfection - Studies of infection and infectious agents
- Registration Number
- ACTRN12619000241134
- Lead Sponsor
- Austin Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
1.Patient of participating hospital during acute SCAR episode
2.Ability to give informed consent or enabled representative (i.e. next of kin , medical power of attorney).
3.Identified by a specialist in the field of drug allergy as having a SCAR reaction, confirmed by two site investigators.
4.Dermatologist and/or immunologist confirmed phenotype or biopsy proven
5.Consistent with disease specific criteria outlined in protocol for: DRESS, AGEP, SJS/TEN, GBFDE
1.Unable to obtain informed consent
2.SCAR specific phenotype listed above that does not meet provided definitions
3.SCAR specific phenotype deemed not appropriate for inclusion as per site investigators
4.Alternative diagnosis for the clinical presentation – e.g. toxic shock syndrome, acute skin graft versus host disease, Kawasaki disease, pustular psoriasis, staphylococcal scalded skin syndrome, autoimmune bullous disease/ immunobullous disorder, autoimmune connective tissue disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of SCAR secondary to antibiotics (single primary outcome)<br>-Causal drugs obtained from data-linkage to medical records and assessment of primary causality by (i) site investigators and (ii) independent reviewers[At one year post commencement of study]
- Secondary Outcome Measures
Name Time Method